Korean J Ophthalmol.  2020 Feb;34(1):67-75. 10.3341/kjo.2019.0115.

Prognostic Factors Related with Surgical Outcome of Vitrectomy in Myopic Traction Maculopathy

Affiliations
  • 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. jiani4@snu.ac.kr

Abstract

PURPOSE
To investigate prognostic factors related to the surgical outcome of vitrectomy in myopic traction maculopathy (MTM).
METHODS
Medical records of patients with MTM who underwent pars plana vitrectomy with internal limiting membrane peeling and follow-up over 12 months were reviewed retrospectively. Best-corrected visual acuity (BCVA), fundoscopic examination and spectral-domain optical coherence tomography findings were evaluated postoperatively. Functional success was defined as visual acuity gain and anatomical success was defined as reduction or resolution of foveoschisis without complications.
RESULTS
This study included 40 eyes of 36 patients. BCVA improved from 0.70 ± 0.44 to 0.63 ± 0.57 logarithm of minimum angle of resolution and central macular thickness decreased from 526.6 ± 132.1 to 277.8 ± 92.1 µm at final follow-up. Functional success was achieved in 24 (60.0%) eyes, and 33 (82.5%) eyes reached anatomical success. Presence of foveal detachment (FD) and higher category of myopic maculopathy were associated with both functional (p = 0.014, 0.021, respectively) and anatomical (p = 0.011, 0.022, respectively) failure. Longer preoperative axial length showed an association with functional failure but not with anatomical failure (p = 0.041). In multivariate analysis, FD was the only prognostic factor for both functional and anatomical outcome (p = 0.041, 0.043, respectively). Preoperative BCVA (r² = 0.259, p = 0.001), axial length (r² = 0.172, p = 0.008), and myopic maculopathy category (r² = 0.336, p < 0.001) showed significant correlation with final BCVA.
CONCLUSIONS
More severe myopic maculopathy and the presence of FD are associated with poorer functional and anatomical outcomes of pars plana vitrectomy in MTM. Better preoperative BCVA, shorter axial length, and less severe myopic maculopathy are correlated with better final BCVA.

Keyword

Myopic foveoschisis; Myopic traction maculopathy; Optical coherence tomography; Vitrectomy

MeSH Terms

Follow-Up Studies
Humans
Medical Records
Membranes
Multivariate Analysis
Retrospective Studies
Tomography, Optical Coherence
Traction*
Visual Acuity
Vitrectomy*

Figure

  • Fig. 1 A case of myopic traction maculopathy with foveal detachment after pars plana vitrectomy. (A) Preoperative and (B) final fundus images are presented. Serial optical coherence tomography images are arranged in chronological sequence: (C) preoperative, (D) 1 month, (E) 4 months, (F) 8 months, (G) 14 months, and (H) final. Visual acuities at each postoperative follow-up are indicated at the bottom right of the optical coherence tomography image.

  • Fig. 2 A case of myopic traction maculopathy after pars plana vitrectomy with gas tamponade. (A) Preoperative and (B) final fundus images are presented. Serial optical coherence tomography images are arranged in chronological sequence: (C) preoperative, (D) 1 month, (E) 4 months, (F) 8 months, (G) 14 months, and (H) final. Visual acuities at each postoperative follow-up are indicated at the bottom right side of the optical coherence tomography image.

  • Fig. 3 A case of myopic traction maculopathy after pars plana vitrectomy without gas tamponade. (A) Preoperative and (B) final fundus images are presented. Serial optical coherence tomography images are arranged in chronological sequence: (C) preoperative, (D) 1 month, (E) 4 months, (F) 8 months, (G) 14 months, and (H) final. Visual acuities at each postoperative follow-up are indicated at the bottom right side of the optical coherence tomography image.

  • Fig. 4 A case of myopic traction maculopathy after pars plana vitrectomy with postoperative macular hole (*) development. (A) Preoperative and (B) final fundus images are presented. Serial optical coherence tomography images are arranged in chronological sequence: (C) preoperative, (D) 1 month, (E) 4 months, (F) 8 months, (G) 14 months, and (H) final. Visual acuities at each postoperative follow-up are indicated at the bottom right side of the optical coherence tomography image.

  • Fig. 5 Changes of (A) best-corrected visual acuity (BCVA) logarithm of minimum angle of resolution (logMAR) and (B) central macular thickness (CMT) at preoperative and different postoperative follow-up periods. *0.01 < p ≤ 0.05, **p ≤ 0.001.

  • Fig. 6 Association between (A) preoperative best-corrected visual acuity (BCVA) logarithm of minimum angle of resolution (logMAR), (B) axial length (mm), (C) myopic maculopathy category and final BCVA (logMAR).


Reference

1. Verkicharla PK, Ohno-Matsui K, Saw SM. Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt. 2015; 35:465–475.
Article
2. Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004; 122:1455–1460.
Article
3. Baba T, Ohno-Matsui K, Futagami S, et al. Prevalence and characteristics of foveal retinal detachment without macular hole in high myopia. Am J Ophthalmol. 2003; 135:338–342.
Article
4. Johnson MW. Myopic traction maculopathy: pathogenic mechanisms and surgical treatment. Retina. 2012; 32:S205–S210.
5. VanderBeek BL, Johnson MW. The diversity of traction mechanisms in myopic traction maculopathy. Am J Ophthalmol. 2012; 153:93–102.
Article
6. Ikuno Y, Gomi F, Tano Y. Potent retinal arteriolar traction as a possible cause of myopic foveoschisis. Am J Ophthalmol. 2005; 139:462–467.
Article
7. Panozzo G, Mercanti A. Vitrectomy for myopic traction maculopathy. Arch Ophthalmol. 2007; 125:767–772.
Article
8. Shimada N, Tanaka Y, Tokoro T, Ohno-Matsui K. Natural course of myopic traction maculopathy and factors associated with progression or resolution. Am J Ophthalmol. 2013; 156:948–957.
Article
9. Kobayashi H, Kishi S. Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis. Ophthalmology. 2003; 110:1702–1707.
10. Futagami S, Inoue M, Hirakata A. Removal of internal limiting membrane for recurrent myopic traction maculopathy. Clin Exp Ophthalmol. 2008; 36:782–785.
Article
11. Kanda S, Uemura A, Sakamoto Y, Kita H. Vitrectomy with internal limiting membrane peeling for macular retinoschisis and retinal detachment without macular hole in highly myopic eyes. Am J Ophthalmol. 2003; 136:177–180.
Article
12. Gaucher D, Haouchine B, Tadayoni R, et al. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. Am J Ophthalmol. 2007; 143:455–462.
Article
13. Gao X, Ikuno Y, Fujimoto S, Nishida K. Risk factors for development of full-thickness macular holes after pars plana vitrectomy for myopic foveoschisis. Am J Ophthalmol. 2013; 155:1021–1027.
Article
14. Kumagai K, Furukawa M, Ogino N, Larson E. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Retina. 2010; 30:874–880.
Article
15. Hwang JU, Joe SG, Lee JY, et al. Microincision vitrectomy surgery for myopic foveoschisis. Br J Ophthalmol. 2013; 97:879–884.
Article
16. Figueroa MS, Ruiz-Moreno JM, Gonzalez del, et al. Long-term outcomes of 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade for myopic traction maculopathy: A Prospective Study. Retina. 2015; 35:1836–1843.
17. Shin JY, Yu HG. Visual prognosis and spectral-domain optical coherence tomography findings of myopic foveoschisis surgery using 25-gauge transconjunctival sutureless vitrectomy. Retina. 2012; 32:486–492.
Article
18. Sayanagi K, Ikuno Y, Soga K, Tano Y. Photoreceptor inner and outer segment defects in myopic foveoschisis. Am J Ophthalmol. 2008; 145:902–908.
Article
19. Hattori K, Kataoka K, Takeuchi J, et al. Predictive factors of surgical outcomes in vitrectomy for myopic traction maculopathy. Retina. 2018; 38:S23–S30.
Article
20. Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol. 2015; 159:877–883.
Article
21. Taniuchi S, Hirakata A, Itoh Y, et al. Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy. Retina. 2013; 33:2018–2025.
Article
22. Ikuno Y, Sayanagi K, Ohji M, et al. Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol. 2004; 137:719–724.
Article
23. Shimada N, Sugamoto Y, Ogawa M, et al. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol. 2012; 154:693–701.
Article
24. Ho TC, Yang CM, Huang JS, et al. Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Retina. 2014; 34:1833–1840.
Article
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr